CCA
MRK icon

Cadent Capital Advisors’s Merck MRK Stock Holding History

Cadent Capital Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$424K Sell
2,915
-63
-2% -$8.71K 0.09% 124
2026
Q2 		$383K Buy
2,978
+18
+0.6% +$2.11K 0.08% 139
2026
Q1 		$356K Buy
2,960
+19
+0.6% +$2.19K 0.09% 131
2025
Q4 		$310K Buy
2,941
+23
+0.8% +$2.16K 0.08% 145
2025
Q3 		$245K Buy
+2,918
New +$240K 0.06% 176
2025
Q1 		– Sell
-2,145
Closed -$213K – 155
2024
Q4 		$213K Buy
2,145
+9
+0.4% +$928 0.07% 143
2024
Q3 		$243K Sell
2,136
-577
-21% -$68.5K 0.07% 139
2024
Q2 		$336K Buy
2,713
+9
+0.3% +$1.16K 0.13% 93
2024
Q1 		$357K Sell
2,704
-207
-7% -$25.5K 0.14% 80
2023
Q4 		$317K Buy
2,911
+230
+9% +$23.9K 0.16% 79
2023
Q3 		$276K Buy
2,681
+10
+0.4% +$1.08K 0.11% 89
2023
Q2 		$308K Buy
2,671
+436
+20% +$49.5K 0.18% 85
2023
Q1 		$238K Buy
2,235
+10
+0.4% +$1.08K 0.11% 110
2022
Q4 		$247K Buy
+2,225
New +$227K 0.12% 103

Other funds holding MRK

MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
CAM
Cacti Asset Management Atlanta, Georgia $1.89B AUM 58.55% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
CA
CapWealth Advisors Franklin, Tennessee $1.32B AUM 21.6% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return
OGC
Oak Grove Capital North Hampton, New Hampshire $2.21B AUM 127.51% 1-Year Est. Return

Cadent Capital Advisors's MRK Position: Q3 2026 in Review

Cadent Capital Advisors reduced its Merck (MRK) stake by 2.1% in Q3 2026, selling an estimated $8.71K and leaving 2,915 shares worth $424K. The position accounts for 0.09% of the portfolio, ranked #124.

Cadent Capital Advisors first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. 203 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Cadent Capital Advisors held 2,915 shares of Merck worth $424K as of Q3 2026.
  • Cadent Capital Advisors sold 63 Merck shares in Q3 2026, an estimated $8.71K.
  • Merck made up 0.09% of Cadent Capital Advisors's portfolio in Q3 2026, its #124 holding.
  • Cadent Capital Advisors first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • 203 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Cadent Capital Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.